In a significant talent acquisition move, Guolian Minsheng Research Institute has welcomed two heavyweight analysts. Zhang Jinyang, formerly the Chief Pharmaceutical Analyst at Guosheng Securities Inc., renowned as the "Innovative Drug Rider," has officially joined with his core team. He assumes the role of Deputy General Manager of the Research Institute and Chief Pharmaceutical Analyst.
Simultaneously, Wang Xianshuang, a rising star in banking research formerly serving as Chief Banking Analyst at China Merchants Securities Co.,Ltd., has also joined with his team. He will take up the positions of Assistant Director of the Research Institute, Chief Banking Analyst, and Dean of the Monetary Finance Research Institute.
This high-profile dual recruitment is not an isolated event. As early as mid-November, Kong Rong, a leading expert in TMT, AI, and the global technology supply chain often referred to as the "Overseas Queen," transferred with her core team. She joined as Deputy General Manager of the Research Institute and Chief Overseas Analyst, aiming to develop premium research with a global perspective and inject strong momentum into the institute's international expansion.
As emphasized by Hu Youwen, General Manager of Guolian Minsheng Research Institute, talent is the most critical asset of the research business. The recent consecutive recruitment of star teams from outside clearly targets the institute's key strategic frontiers: overseas markets, innovative drugs, and major financial sectors. By directly integrating mature, top-tier, and fully-formed star teams, Guolian Minsheng Research Institute is rapidly strengthening its capabilities in industrial chain research, achieving "plug-and-play" expertise and a significant leap in competence within crucial areas.
Zhang Jinyang's team, leveraging its profound expertise and professional insight into innovative drugs, has won numerous awards including the Golden Bull Award, Crystal Ball Award, and Golden Kylin Award multiple times between 2016 and 2025. From 2019 to 2025, they ranked in the top three of the New Fortune rankings four times. In 2025, the team accurately predicted the "Deepseek moment" for innovative drugs, a call that ignited a bull market in A-shares and H-shares, cementing their reputation as "industry prophets."
The newly recruited team led by Wang Xianshuang strengthens the financial sector, hitting the ground running. From 2019 to 2024, his core leadership secured first place in both the Golden Bull and Crystal Ball Awards, while consistently achieving third place in the New Fortune rankings. In 2025, leading his own team, the performance was even more formidable, directly breaking into the Securities Times' Best Analyst list. The team has continuously deepened its analysis of credit and bank stocks, first proposing the "FVOCI account to avoid volatility" concept, predicting insurance capital's increased stakes in listed companies, and advocating for the banking industry to "counter internal competition," sparking widespread industry discussion.
The flow of top talent towards the year-end often best reflects a platform's comprehensive appeal and growth potential. Guolian Minsheng Securities, a benchmark in industry mergers, has its research institute led by a New Fortune Platinum Analyst and bolstered by the first "Hundred-Star Analyst." All core sectors have deeply integrated "New Fortune-caliber" research teams, building a comprehensive research system with both depth and foresight, creating a deep and wide "moat" of research capability. On this continuously upgrading, first-class platform, star analysts not only gain vast development space but can also ride the platform's momentum to fully unleash their research potential and foster innovative thinking. This is precisely why numerous top teams are converging here—where individual excellence and platform empowerment resonate, jointly unlocking a new future for a top-tier investment research ecosystem.
"The most important thing in the 21st century? Talent!" Within just one month, securing three major victories and assembling an ace team—based on this magnetic appeal for top talent, the rapidly developing Guolian Minsheng Securities Research Institute's future is certainly one to watch.
Comments